Dr. Matthew M. McCormick
Principal Engineer at Kitware, Inc
SPIE Involvement:
Author | Instructor
Publications (3)

Proceedings Article | 15 March 2019
Proc. SPIE. 10953, Medical Imaging 2019: Biomedical Applications in Molecular, Structural, and Functional Imaging
KEYWORDS: Statistical analysis, Matrices, Diagnostics, Feature extraction, Image analysis, Bone, Medical imaging, Dentistry, Statistical methods

Proceedings Article | 15 March 2019
Proc. SPIE. 10953, Medical Imaging 2019: Biomedical Applications in Molecular, Structural, and Functional Imaging
KEYWORDS: Principal component analysis, Injuries, Statistical analysis, Tissues, 3D modeling, Image analysis, Bone, Shape analysis, Analytical research, 3D image processing

Proceedings Article | 12 March 2018
Proc. SPIE. 10578, Medical Imaging 2018: Biomedical Applications in Molecular, Structural, and Functional Imaging
KEYWORDS: Principal component analysis, Statistical analysis, Tissues, Diagnostics, Bone, Computed tomography, Biological research

Course Instructor
SC1182: ITK in Biomedical Research and Commercial Applications
The Insight Segmentation and Registration Toolkit (www.itk.org) has become a standard in academia and industry for medical image analysis. In recent years, the ITK developers' community has focused on providing programming interfaces to ITK from Python, Java, and Javascript and making ITK available via leading applications such as Slicer and ImageJ. In this course we present best practices for taking advantage of ITK in your imaging research and commercial products. Via interactive examples that attendees can run on their laptops during the course, we show how ITK can speed research and commercial product development. We demonstrate how script writing and interactive GUIs can be used to access the algorithms in ITK and the multitude of ITK extensions that are freely available on the web. We also cover the opportunities and challenges with using open-source software in research and in commercial applications: from prototypes that can lead to venture capital funding to applications for first-in-human trials and ultimately for regulatory approval.
SIGN IN TO:
  • View contact details

UPDATE YOUR PROFILE
Is this your profile? Update it now.
Don’t have a profile and want one?

Advertisement
Advertisement
Back to Top